Stock ARYD ARYA SCIENCES ACQUISITION CORP IV
Add to a list
To use this feature you must be a member
Log inSign up

Highlights ARYA Sciences Acquisition Corp IV

Equities

ARYD

KYG316591083

Market Closed - Nasdaq
Other stock markets
 03:55:23 2024-07-15 pm EDT 		5-day change 1st Jan Change
11.56 USD +0.35% Intraday chart for ARYA Sciences Acquisition Corp IV +0.35% +6.06%
Jun. 28 ARYA Sciences Acquisition Corp IV announced that it has received $0.15 million in funding from ARYA Sciences Holdings IV CI
May. 20 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023
CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2022
CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Amicus Therapeutics Loss Narrows, Revenue Rises in 2021; Terminates ARYA Sciences Combination Over Market Conditions
MT
Gene Therapy Business of Amicus Therapeutics, Inc. cancelled the acquisition of ARYA Sciences Acquisition Corp IV from Todd Wider, Leslie Trigg and Michael Henderson, ARYA Sciences Holdings IV and others in a reverse merger transaction.
CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
ARYA Sciences Acquisition Corp IV Provides Earnings Guidance for the Year 2021
CI
Amicus Therapeutics : Arya Sciences Acquisition Corp to Create Genetic Medicine Company Caritas Therapeutics
MT
Gene Therapy Business of Amicus Therapeutics, Inc. entered into a non-binding agreement to acquire ARYA Sciences Acquisition Corp IV from Todd Wider, Leslie Trigg and Michael Henderson, ARYA Sciences Holdings IV and others in a reverse merger transaction.
CI
Arya Sciences Acquisition Corp Iv Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Arya Sciences Acquisition Corp Iv Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
ARYA Sciences Acquisition Corp IV has completed an IPO in the amount of $130 million.
CI
ARYA Sciences Acquisition Corp IV has filed an IPO in the amount of $130 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ARYD Stock
  4. News ARYA Sciences Acquisition Corp IV
  5. Highlights